Luke, Jason, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors (NCT05469490) | Luke, Jason, MD | 2022-10-01 |
Track Luke, Jason, MD automatically
Every clearance here is in the API, with alerts when new ones post.